header logo image

Iovance Biotherapeutics to Present at Upcoming Conferences in December

November 30th, 2020 7:57 am

SAN CARLOS, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences in November:

Go here to read the rest:
Iovance Biotherapeutics to Present at Upcoming Conferences in December

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick